Johan Wedell-Wedellsborg - Dec 11, 2023 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
Director
Signature
/s/ Johan Wedell-Wedellsborg
Stock symbol
YMAB
Transactions as of
Dec 11, 2023
Transactions value $
$44,232
Form type
4
Date filed
12/12/2023, 08:26 AM
Previous filing
Dec 11, 2023
Next filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Purchase $44.2K +6.46K +0.14% $6.85 4.56M Dec 11, 2023 By WG Biotech ApS F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $6.85 to $6.86. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares.